Clinical Trials Network, Ohio Valley Node
临床试验网络,俄亥俄谷节点
基本信息
- 批准号:7498313
- 负责人:
- 金额:$ 95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-30 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:14 year oldAIDS preventionAIDS/HIV problemAbbreviationsAbsorbent PadsAbstinenceAccident and Emergency departmentAccountabilityAccountingAcetaldehydeAcquired Immunodeficiency SyndromeAcuteAddressAdhesivesAdministratorAdolescentAdolescent MedicineAdoptedAdoptionAdultAdverse drug effectAdverse effectsAdverse eventAdvertisingAfricanAfrican AmericanAftercareAgeAge-YearsAgreementAlaska NativeAlcohol abuseAlcohol consumptionAlcohol dependenceAlcohol or Other Drugs useAlcoholismAlcoholsAlgorithmsAll SitesAllelesAmendmentAmericanAmerican IndiansAmphetaminesAnatomyAngiographyAnguishAnimal BehaviorAnti-Anxiety AgentsAnticonvulsantsAntihypertensive AgentsAnxietyAppalachian RegionAppendixAppointmentAreaAsiansAttentionAuthorization documentationAuthorshipBackBaclofenBasic ScienceBeck depression inventoryBehaviorBehavior TherapyBehavioralBehavioral SciencesBilateralBiologicalBiomedical EngineeringBipolar DisorderBloodBlood Chemical AnalysisBlood PressureBostonBrainBudgetsBuprenorphineBupropionBurn injuryBusinessesCarbamazepineCarboxylic Ester HydrolasesCardiacCardiovascular DiseasesCardiovascular systemCaringCase ManagementCase Report FormCategoriesCaucasiansCaucasoid RaceCellular biologyCertificationChairpersonCharacteristicsCheek structureChemicalsChestChicagoChildCitiesClinicClinicalClinical ManagementClinical Practice GuidelineClinical ResearchClinical TrialsClinical Trials Data Monitoring CommitteesClinical Trials DesignClinical Trials NetworkCocaineCocaine DependenceCocaine UsersCodeCognitiveCognitive TherapyCollaborationsCommitCommittee MembersCommunicable DiseasesCommunicationCommunitiesCommunity PharmacyCommunity SurveysComorbidityComplexComplicationComputer HardwareComputer SystemsComputer softwareConcept ReviewConditionConduct Clinical TrialsConnecticutConsensusConsentConsent FormsConsultationsContact InfoContractsControl GroupsCounselingCountCountryCountyCrack CocaineCriminal JusticeCrisis InterventionCultural DiversityCutaneousCytosineDSM-IVDailyDataData AnalysesData CollectionData ReportingDatabasesDay CareDeath RateDecision MakingDedicationsDependenceDependencyDepressed moodDetoxDevelopmentDevelopment PlansDevelopment, OtherDiagnosisDiagnosticDictionaryDiethyldithiocarbamateDiffusionDiffusion of InnovationDisadvantagedDisciplineDiseaseDistantDisulfiramDizzinessDoctor of MedicineDoctor of PhilosophyDocumentationDomestic ViolenceDopamineDopamine-beta-monooxygenaseDoseDouble-Blind MethodDropsDrowsinessDrug AddictionDrug CourtsDrug KineticsDrug Metabolic DetoxicationDrug MonitoringDrug abuseEating DisordersEconomicsEducationEducational StatusEffectivenessEffectiveness of InterventionsElectrocardiogramElectrophysiology (science)ElementsEligibility DeterminationEmploymentEncapsulatedEnrollmentEnsureEnvironmentEnzymesEquationEquilibriumEquipment and supply inventoriesEthanolEthnic OriginEthnic groupEuphoriaEvaluationEvidence based practiceEvidence based treatmentEvolutionExcisionExclusion CriteriaExpenditureExposure toFaceFacultyFamilyFamily memberFamily psychotherapyFeedbackFeesFemaleFemale AdolescentsFloridaFlushingFosteringFoundationsFrequenciesFundingFutureGABA ReceptorGamblingGenderGender IssuesGenerationsGeneric DrugsGenesGeneticGenetic PolymorphismGeographic LocationsGhettoGoalsGoverning BoardGrantGraphGray unit of radiation doseGroup MeetingsGuidelinesHIVHIV InfectionsHalf-LifeHandHaplotypesHeadHeadacheHealthHealth PersonnelHealth ServicesHearingHearing Impaired PersonsHeartHeart DiseasesHeart RateHematologyHepaticHepatitis CHepatotoxicityHeroinHeroin DependenceHispanicsHomelessnessHornsHourHousingHumanHuman GeneticsHuman ResourcesHuman immunodeficiency virus testHuntington DiseaseHypnotics and SedativesHypotensionIllinoisImageImmersion Investigative TechniqueImprisonmentIncentivesIncidenceIndianaIndividualInformation TechnologyInformed ConsentIngestionInpatientsInstitute of Medicine (U.S.)InstitutionInstructionInsuranceIntakeInterest GroupInternationalInternetInterventionInterviewInterviewerInvestigationInvestigational New Drug ApplicationIowaJailJob DescriptionJointsJudgmentKentuckyKetoconazoleKnowledgeLabelLaboratoriesLaboratory StudyLanguageLawsLeadLeadershipLeftLettersLevetiracetamLicensingLifeLimesLinear ModelsLiteratureLiverLiver Function TestsLocationLong IslandLow incomeMagnetic Resonance ImagingMagnetismMailsMaintenanceMaintenance TherapyManualsMarijuanaMeasurementMeasuresMedicaidMedicalMedical StaffMedical centerMedication ManagementMedicineMental DepressionMental HealthMentally Ill PersonsMentorsMetabolismMethadoneMethodologyMethodsMethyl GreenMethylphenidateMetyraponeMexicoMinnesotaMinorMinorityMissionMississippiMissouriMixed Function OxygenasesModafinilModalityModelingMolecular and Cellular BiologyMonitorMonitoring Clinical TrialsMorphineMothersMotivationMulti-Institutional Clinical TrialMycosesNaloxoneNaltrexoneNamesNational Institute of Drug AbuseNative AmericansNauseaNetwork-basedNeurobiologyNeurologicNeurosciencesNew YorkNickelNicotineNorepinephrineNumbersObject AttachmentOffice of Administrative ManagementOhioOperative Surgical ProceduresOpiate AddictionOpiatesOpioidOpioid ReceptorOregonOutcomeOutcome MeasureOutpatientsOxygenPI protocolPTGS1 genePacific Island AmericansPainPan GenusPanicPaperParanoiaParent-Child RelationsParticipantPathway interactionsPatient AdmissionPatient CarePatient Self-ReportPatient currently pregnantPatientsPediatric HospitalsPediatricsPerformancePersonal SatisfactionPersonsPharmaceutical PreparationsPharmacistsPharmacologic SubstancePharmacological TreatmentPharmacologyPharmacy facilityPhasePhysician ExecutivesPhysiciansPhysiologicalPlacebo ControlPlacebosPlasmaPlayPoliciesPopulationPositioning AttributePovertyPregnancy TestsPregnant WomenPrejudicePreparationPreventionPrevention educationPrevention interventionPrevention programPrincipal InvestigatorPrisonerProceduresProcessProductivityProgress ReportsPropertyProtocol ComplianceProtocols documentationProviderPsychiatristPsychiatryPsychological reinforcementPsychologyPsychometricsPsychotherapyPublic HealthPublicationsPublished CommentPublishingPurposeQualifyingRPS19 geneRaceRainRandomizedRandomized Clinical TrialsRandomized Controlled Clinical TrialsRandomized Controlled TrialsRangeRateReactionReadinessReadingReceptor GeneRecoveryRecruitment ActivityRegulatory AffairsRelapseReportingReproductive HealthReproductive Health ServicesResearchResearch ActivityResearch DesignResearch Ethics CommitteesResearch InfrastructureResearch PersonnelResearch TrainingReserpineResidential TreatmentResistanceResolutionResourcesReview CommitteeRewardsRiboflavinRightsRiotsRiskRisk BehaviorsRisk ReductionRisk-TakingRiversRoleRole playing therapyRouteRunningRuralSafetySample SizeSamplingSavingsScheduleSchoolsScienceScoreScreening procedureSecureSelection CriteriaSelegilineSelf-AdministeredSeriesSerious Adverse EventSertralineServicesSevere Adverse EventSeveritiesSeverity of illnessSexually Transmitted DiseasesShippingShipsSignal TransductionSingle Nucleotide PolymorphismSiteSite VisitSkinSleeplessnessSlideSmokingSoftware EngineeringSolidSolutionsSourceSpecific qualifier valueSpecificitySpectrum AnalysisStagingStandards of Weights and MeasuresStructureStudentsStudy SubjectSubstance AddictionSubstance Use DisorderSubstance abuse problemSupervisionSurveysSweatSweatingSyndromeSystemTabletsTarget PopulationsTattooingTechniquesTechnologyTechnology TransferTeleconferencesTelefacsimileTelephoneTerminologyTestingTextTherapeutic community techniqueThinkingThird-Party PayerThymineTimeTime StudyTimeLineTinTitleTobaccoTobacco DependenceTouch sensationToxic effectToxicologyTrainers TrainingTrainingTraumaTreatment ProtocolsTreatment outcomeTurtlesUcaUltraviolet RaysUnemploymentUnited StatesUnited States Food and Drug AdministrationUnited States National Institutes of HealthUnited States Substance Abuse and Mental Health Services AdministrationUniversitiesUpdateUpper armUrban PopulationUrinalysisUrineVariantVeteransVigabatrinVisionVisitVotingWagesWashingtonWaterWeekWest VirginiaWisconsinWomanWorkWorld Health OrganizationWritingY baseYouthacamprosateaddictionagedalcohol abuse therapyalcohol and other drugalcohol researchbasebenzoylecgoninebirth controlblindcaN protocolcarboxylesterasecare systemschild bearingchild protective servicecigarette smokingclinical efficacyclinical research siteclinically relevantclinically significantcocaethylenecohortcollegecommunity based servicecompliance behaviorcomputer monitorcomputerized data processingconceptcontingency managementcostcravingcyclooxygenase 1data integritydata managementdatabase designdaydemographicsdesigndonepezildosagedrinkingdrug abuserdual diagnosisdysphoriaecgonine methyl esterethnic minority populationexperiencefallsfightingfollow-upgabapentingroup counselinghealth care service utilizationhigh schoolhuman subjecthypnoticimprovedindexinginnovationinsightinstrumentinterestlamotriginemalemedication compliancemembermenmen who have sex with menmethadone clinic/centermetropolitanmotivational enhancement therapymu opioid receptorsmutantnamed groupneurochemistryneuroimagingneutrophiloffenderorganizational structureoutreachoxcarbazepinepeginterferon alfa-2bplacebo controlled studypregnancy hypertensionpreventprobationprofessorprogramsprotocol developmentpsychosocialquality assuranceresearch and developmentresearch studyresponsesafer sexsatisfactionsexsizeskillssmoking cessationsocialspecial interest groupstatisticssubstance abusersuccesssymposiumtherapy developmenttiagabinetooltopiramatetraining projecttransmission processtreatment centertreatment durationtreatment programtrendvalproatevolunteervoucherwastingwillingness
项目摘要
The Ohio Valley Node (OVN) joined NIDA's Clinical Trials Network (CTN) four years ago, as one of the CTN's
second wave of grantees. From the very beginning, the OVN has been a highly effective, enthusiastic, and energetic
node that has excelled in providing scientific and administrative leadership, in collaborating with other nodes andwith
NIDA staff, and in disseminating informationabout evidence-based practice and the results of CTN studies. Moreover,
the OVN has developed a model bi-directional relationship between its University of Cincinnati-affiliated Regional
Research and Training Center (RRTC) and its six original ("core") community treatment programs (CTPs), which are
located in Ohio, Indiana, Kentucky, and West Virginia.
In this continuation application, the OVN proposes to enhance the geographical and cultural diversity of the CTN by
expanding the OVN's Midwestern and Appalachian presence in the network and adding a Mississippi Delta component,
via nine additional "protocol-specific" CTPs in five additional states. The fifteen OVN CTPs, which together treat more
than 52,000 patients a year, will contribute significantly to the number and variety of potential participants for CTN
studies. Each of the core OVN CTPs has participated in at least one CTN clinical trial and two survey studies., and all
six will continue to share in the administration of the node and in its development of research concepts and protocols.
Although the new protocol-specific CTPs will play a more limited role, they are looking forward with enthusiasm to
participating in appropriate clinical trials, providing an expanded and enriched patient population to the CTN.
During the OVN's first four years in the CTN, we have immersed ourselves fully in all of its activities. We have
submitted nine protocol concepts, of which five were chosen for further development; two have been converted into full
protocols, including one which is currently enrolling participants. We have been active in the national committees of
the CTN, providing five committee chairs and authoring or contributing to many SOPs and "guidance" documents.
Unique contributions by the OVN include a system used CTN-wide for monitoring and reporting on staff training
requirements and accomplishments, a system for tracking the progress of CTN clinical trials, and a template used to
standardize the organization of CTN node budgets. The sense of satisfaction we feel in these and other
accomplishments, together with the urgency we feel to continue working on the important search for effective
reatments for substance abuse, make us eager to continue the work we have begun.
俄亥俄州谷节点(OVN)四年前加入了NIDA的临床试验网络(CTN),这是CTN之一
第二波受赠人。从一开始,OVN一直是一个非常有效,热情和充满活力的
与其他节点合作,在提供科学和行政领导方面表现出色的节点
NIDA的工作人员,并传播信息基于证据的实践和CTN研究的结果。而且,
OVN已经建立了辛辛那提大学附属区域之间的模型双向关系
研究与培训中心(RRTC)及其六个原始(“核心”)社区治疗计划(CTPS)
位于俄亥俄州,印第安纳州,肯塔基州和西弗吉尼亚州。
在这种延续应用中,OVN建议通过
扩展OVN在网络中的中西部和阿巴拉契亚的存在,并添加密西西比三角洲组件,
通过在五个其他状态下的九个其他“协议特定” CTP。十五个OVN CTP,共同治疗更多
每年超过52,000名患者将对CTN的潜在参与者的数量和种类贡献很大
研究。每个核心OVN CTPS都参加了至少一项CTN临床试验和两项调查研究。
六个将继续分享节点的管理及其研究概念和协议的发展。
尽管新的协议特定的CTP将扮演更有限的角色,但他们热情地期待着
参加适当的临床试验,为CTN提供扩大且丰富的患者人群。
在OVN在CTN中的头四年中,我们将自己完全沉浸在其所有活动中。我们有
提交了九个协议概念,其中五个是为了进一步发展的;两个已转换为完整
协议,包括目前正在招募参与者的协议。我们一直活跃于国家委员会
CTN提供五个委员会主席,并为许多SOP和“指导”文件贡献或贡献或贡献。
OVN的独特贡献包括用于监视和报告员工培训的系统范围内的系统
要求和成就,一种用于跟踪CTN临床试验进度的系统,以及用于
标准化CTN节点预算的组织。我们在这些和其他方面的满足感
成就,以及我们认为继续进行重要搜索以寻求有效的紧迫性
滥用药物的布局,使我们渴望继续我们已经开始的工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EUGENE C. SOMOZA其他文献
EUGENE C. SOMOZA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EUGENE C. SOMOZA', 18)}}的其他基金
Multisite Controlled Trial of Cocaine Vaccine (2 of 6) Cincinnati Treatment Site
可卡因疫苗多中心对照试验(6 中的 2)辛辛那提治疗中心
- 批准号:
8271728 - 财政年份:2008
- 资助金额:
$ 95万 - 项目类别:
Multisite Controlled Trial of Cocaine Vaccine (2 of 6) Cincinnati Treatment Site
可卡因疫苗多中心对照试验(6 中的 2)辛辛那提治疗中心
- 批准号:
8225238 - 财政年份:2008
- 资助金额:
$ 95万 - 项目类别:
Multisite Controlled Trial of Cocaine Vaccine (2 of 6) Cincinnati Treatment Site
可卡因疫苗多中心对照试验(6 中的 2)辛辛那提治疗中心
- 批准号:
7514796 - 财政年份:2008
- 资助金额:
$ 95万 - 项目类别:
Multisite Controlled Trial of Cocaine Vaccine (2 of 6) Cincinnati Treatment Site
可卡因疫苗多中心对照试验(6 中的 2)辛辛那提治疗中心
- 批准号:
7683035 - 财政年份:2008
- 资助金额:
$ 95万 - 项目类别:
Clinical Trials Network, Ohio Valley Node U10DA013732
临床试验网络,俄亥俄谷节点 U10DA013732
- 批准号:
7983629 - 财政年份:2000
- 资助金额:
$ 95万 - 项目类别:
相似国自然基金
去医学化综合性艾滋病暴露前预防决策支持系统及优化
- 批准号:72364039
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
新策略下我国艾滋病预防干预措施效果评估动态模型的构建和应用
- 批准号:81803334
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于系统动力学的预防艾滋病经家庭内传播研究
- 批准号:71774150
- 批准年份:2017
- 资助金额:48.0 万元
- 项目类别:面上项目
基于社会心理-行为协同效应的男男性行为者预防艾滋病干预措施及策略研究
- 批准号:71603166
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
基于创新扩散理论的广西农村校外青少年预防艾滋病互联网+健康教育干预研究
- 批准号:71663013
- 批准年份:2016
- 资助金额:30.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Bridges-Round 2: Evaluating the Long-term Impact of a Family Economic Empowerment Intervention on HIV Risk Prevention and Care Continuum Outcomes among Orphaned Youth Transitioning to Young Adulthood
Bridges-Round 2:评估家庭经济赋权干预措施对过渡到青年时期的孤儿青少年的艾滋病毒风险预防和护理连续结果的长期影响
- 批准号:
10405349 - 财政年份:2022
- 资助金额:
$ 95万 - 项目类别:
An Accessible Digital Intervention to Promote HIV Testing/Counseling and Prevention Among Adolescents
促进青少年艾滋病毒检测/咨询和预防的便捷数字干预措施
- 批准号:
9405690 - 财政年份:2016
- 资助金额:
$ 95万 - 项目类别:
Neural Response to Risky Decision Making in Youth at High Risk for Substance Use Disorders and HIV
药物使用障碍和艾滋病毒高危青少年对危险决策的神经反应
- 批准号:
9285769 - 财政年份:2016
- 资助金额:
$ 95万 - 项目类别:
Intervention to encourage HIV Testing and Counseling among Adolescents
鼓励青少年进行艾滋病毒检测和咨询的干预措施
- 批准号:
9146463 - 财政年份:2016
- 资助金额:
$ 95万 - 项目类别: